AwardTape · Defense awards · Research and development · Health R&D · W911SR25C0013
W911SR25C0013: $204K definitive contract to Cygnos Biotech, LLC
Cygnos Biotech, LLC holds a definitive contract from Department of the Army with $204K obligated since Oct 2023, against a ceiling of $204K. Latest action Mar 4, 2025.
Research to create a class of agnostic drugs targeting the host to assist in fighting off a broad spectrum of viral pathogens.
| PIID | W911SR25C0013 |
|---|---|
| Type | definitive contract |
| Company | Cygnos Biotech, LLC |
| Agency | Department of the Army |
| Contracting office | W6QK ACC-APG |
| Category | Research and development · Health R&D |
| PSC | AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541714 RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| Obligated since Oct 2023 | $204K |
| Total obligated (lifetime) | $204K |
| Ceiling (base and all options) | $204K |
| Base date | Mar 4, 2025 |
| Latest action | Mar 4, 2025 |
| End date | Sep 8, 2025 |
| Actions since Oct 2023 | 1 |
| Pricing | Firm fixed price |
| Competition | Competed after exclusion of sources |
| Place of performance | FL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial